Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2025-01-14 Regulatory Filings
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024. It is a compliance certificate from the company's Registrar and Share Transfer Agent confirming that the regulation is not applicable as all shares are in demat form and no rematerialisation or dematerialisation requests were received. The document is addressed to stock exchanges and is a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is also short (2269 characters) and serves as a certification letter. Therefore, it fits best under Regulatory Filings (RNS) as an officer certification/compliance document rather than a financial report or announcement.
2025-01-14 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window for insiders in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the period of closure around the declaration of quarterly financial results but does not contain any financial data or results itself. The document is short (1658 characters) and serves as an announcement related to insider trading restrictions rather than a financial report or earnings release. Therefore, it does not fit categories like Earnings Release (ER) or Interim Report (IR). It is best classified as a Regulatory Filing (RNS), which covers compliance-related announcements and miscellaneous regulatory communications that do not fit other categories.
2024-12-27 English
Resignation
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of the Secretarial Auditor of the company. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes details about the resignation, reasons, and a resignation letter. The document does not contain financial statements, audit opinions, or detailed financial data. It is an announcement of a change in a key compliance role rather than a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2024-11-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on November 15, 2024, discussing the financial results for the quarter ended September 30, 2024. It includes management commentary on financial performance, operational updates, CAPEX, product registrations, and a Q&A session with analysts. The presence of detailed financial figures, management discussion, and Q&A confirms this is a full transcript of the earnings call rather than a brief earnings release or a presentation. Therefore, the document fits the definition of a Call Transcript (CT).
2024-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a letter addressed to stock exchanges regarding the availability of an audio recording of an earnings conference call held on November 15, 2024, discussing financial results for the quarter ended September 30, 2024. It references the earnings call but does not contain the transcript or detailed financial data itself. The document is short (1276 characters) and primarily serves to notify the availability of the recording on the company's website. According to the classification rules, such notifications about earnings calls or their recordings fall under Call Transcript (CT) if the transcript is provided, but since this is only an announcement of the audio recording, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement. However, given the specific nature of the content (announcement of earnings call recording), the closest specific category is Call Transcript (CT) because it relates directly to the earnings call content, even though it is an announcement of the recording rather than the transcript itself. The confidence is high because the document clearly relates to an earnings call recording announcement.
2024-11-15 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is dated November 14, 2024, and is addressed to stock exchanges in India, referencing the publication of financial results for the quarter ended September 30, 2024. It mentions the board meeting held on November 13, 2024, where the financial results for the quarter were considered and approved. The document includes a statement of standalone and consolidated financial results for the quarter ended September 30, 2024, with detailed financial data such as total income, profit before tax, tax expenses, profit after tax, comprehensive income, equity share capital, and earnings per share. The length of the document is substantial (15,000 characters), and it contains actual financial statements and substantive financial data for a period shorter than a full fiscal year (quarterly). This matches the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a certification but contains detailed financial results and analysis for the quarter. Therefore, the correct classification is Interim / Quarterly Report (IR). Q2 2025
2024-11-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.